ClinicalTrials.gg
Sign In

Papilloma clinical trials

The registry lists 88 studies for Papilloma across more than 10 countries. 19 are recruiting or about to start. 77 of them are mainly about Papilloma (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-06.

Get an email when these change. Save the Papilloma studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
45
Recruiting
15
Terminated
8
Status unknown
7
Active, not recruiting
5
Withdrawn
4

Phase

Phase 2
14
Phase 4
6
Phase 3
4
Phase 1
2
Early Phase 1
1

Where

United States
51
Belgium
5
France
3
China
3
United Kingdom
2
Italy
2

Who runs them

UNC Lineberger Comprehensive Cancer Center (3) · Massachusetts Eye and Ear Infirmary (2) · National Institute of Allergy and Infectious Diseases (NIAID) (2) · Merck Sharp & Dohme LLC (2) · Indiana University (2) · University of Florida (2) · Boston University (2) · Purdue University (1)

What is being tested here

Drugs under test in Papilloma studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Cisplatin101
Carboplatin101
Bevacizumab001
Interferon Alpha001
Cidofovir001
Verpasep caltespen001
3,3'-diindolylmethane001
Celecoxib001
Propranolol011

Coming up

0phase 3 studies under way
10studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 10

Who these studies take

Of the 15 Papilloma studies recruiting now, 4 (27%) set no upper age limit and 11 (73%) stop at 75 or younger. 1 (7%) take children under 18. 9 (60%) are for women only and 1 (7%) for men only; 7 (47%) take healthy volunteers.

Recruiting studies that take each age, of 15
AgeWomenMen
101 (7%)1 (7%)
187 (47%)5 (33%)
3013 (87%)5 (33%)
4012 (80%)5 (33%)
508 (53%)4 (27%)
656 (40%)4 (27%)
754 (27%)3 (20%)
854 (27%)3 (20%)

Across all 88 studies, recruiting or not: 65% stop at 75 or younger and 61% at 65; 34% take children; 47% are for women only and 8% for men only; 49% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Papilloma studies take

Of 28 interventional studies with no phase under Papilloma, half reached primary completion within 27 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase27 mo8–38 · 28 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 88. Browse all 88 → or search them.